IL1B and epilepsy: IL-1ß is also implicated in the pathogenesis of epilepsy associated with neuroinflammation and this prompted the use of anakinra for treatment of refractory seizure disorders, since anakinra is a small molecule that can pass through the intact blood brain barrier (BBB) (147, 148).